[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100559072":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":11,"centralContacts":16,"locations":21,"responsibleParty":40,"collaborators":10,"id":44,"slug":10,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":47,"acronym":10,"eligibilityCriteria":48,"healthyVolunteers":45,"sex":49,"minAge":50,"maxAge":10,"enrollmentInfo":51,"targetDuration":10,"studyType":54,"phases":10,"briefSummary":55,"conditions":56,"keywords":59,"overallStatus":24,"whyStopped":10,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":69},{"fullName":5,"class":6},"Shanghai Jiao Tong University School of Medicine","OTHER",[8],{"label":9,"type":10,"description":9,"interventionNames":10},"68Ga-FAPI PET\u002FCT",null,[12],{"name":13,"affiliation":14,"role":15},"Xiaosong Chen","Shanghai Jiao Tong University, School of Medicine, Affiliated Ruijin Hospital","PRINCIPAL_INVESTIGATOR",[17],{"name":13,"role":18,"phone":19,"phoneExt":10,"email":20},"CONTACT","86-21-64370045","zsj_mu@yeah.net",[22],{"facility":23,"status":24,"city":25,"state":26,"zip":27,"country":28,"cosmosGeoPoint":29,"geoPoint":34,"contacts":35},"Shanghai Jiao Tong University School of Medicine, Ruijin Hospital","RECRUITING","Shanghai","Shanghai Municipality","200020","China",{"type":30,"coordinates":31},"Point",[32,33],121.45806,31.22222,{"lat":33,"lon":32},[36],{"name":37,"role":18,"phone":38,"phoneExt":10,"email":39},"Chao Hu, M.D. & Ph.D.","+86 13817282551","chaohu1988@hotmail.com",{"type":41,"investigatorFullName":42,"investigatorTitle":43,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"SPONSOR_INVESTIGATOR","Kunwei Shen","Professor","100559072",false,"NCT06559371","68Ga FAPI PET\u002FCT Evaluation of Axillary Lymph Node Status After Neoadjuvant Therapy in Patients With Clinical Axillary Lymph Node Positive Breast Cancer","Inclusion Criteria:\n\n* Female patients aged 18 and above\n* ECOG score 0-2 points\n* Pathological confirmation of malignant breast tumor\n* Clinical axillary lymph node positivity (cN+)\n* Completed at least 3 courses of neoadjuvant therapy and subjected to undergo surgical treatment\n* Informed consent form signed\n\nExclusion Criteria:\n\n* Distant metastasis\n* Unable to complete the proposed neoadjuvant therapy plan\n* Pregnancy","FEMALE","18 Years",{"count":52,"type":53},150,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to learn whether 68Ga-FAPI PET\u002FCT may be used as a new effective methods for evaluating axillary lymph node efficacy after neoadjuvant treatment for breast cancer. The main question it aims to answer is:\n\nCould 68Ga-FAPI PET\u002FCT effectively evaluate axillary lymph node after neoadjuvant treatment for breast cancer? Participants will have a 68Ga-FAPI PET\u002FCT test between last neoadjuvant therapy and surgery.",[57,58],"BREAST CANCER","PET\u002FCT",[57,58],"2025-12-21",{"date":62,"type":63},"2025-12-29","ACTUAL",{"date":65,"type":63},"2024-08-30",{"date":67,"type":53},"2026-06-30",{"name":42,"class":6},1]